{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:40:15Z","timestamp":1789400415749,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>We investigated whether thyroid function could be associated with obesity phenotypes amongst euthyroid individuals.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>A cross-sectional analysis was conducted among healthy, euthyroid subjects. The study participants were chosen from the Tehran Thyroid Study (TTS). We analyzed 2988 euthyroid adults and classified them into four obesity phenotype groups: metabolically healthy normal weight (MHNW), metabolically healthy obese (MHO), metabolically unhealthy normal weight (MUNW), and metabolically unhealthy obese (MUO). The statistical differences between thyroid hormones between various obesity phenotypes according to age and sex was compared using analysis of covariance (ANCOVA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>It was found that MHNW participants had higher levels of FT4 when compared with metabolically healthy or unhealthy obese subjects (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), even after adjustment for the confounding variables. No difference was observed in the levels of TSH (<jats:italic>P<\/jats:italic>\u2009=\u20090.260) among obesity phenotypes. In the subgroup analysis according to the age, a significant difference was observed in the level of FT4 only in subjects with age\u2009&lt;\u200955\u00a0years (<jats:italic>P<\/jats:italic>\u2009=\u20090.001). However, analyzing men and women separately did not show a significant difference in the FT4 level among obesity phenotypes (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>\u201cMetabolically abnormality\u201d was independently related to low normal FT4 levels in overweight\/obese euthyroid individuals. There is a need for further research to understand how low FT4 levels are linked to metabolically unhealthy states in euthyroid individuals.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-023-01135-1","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T03:31:26Z","timestamp":1685417486000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Association between thyroid function and obesity phenotypes in healthy euthyroid individuals: an investigation based on Tehran Thyroid Study"],"prefix":"10.1186","volume":"28","author":[{"given":"Behnaz","family":"Abiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein Ramezani","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Mahdavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atieh","family":"Amouzegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Valizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"1135_CR1","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","volume":"384","author":"M Ng","year":"2014","unstructured":"Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766\u201381.","journal-title":"Lancet"},{"key":"1135_CR2","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nrc3174","volume":"11","author":"MJ Khandekar","year":"2011","unstructured":"Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer. 2011;11:886\u201395.","journal-title":"Nat Rev Cancer"},{"key":"1135_CR3","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"SE Kahn","year":"2006","unstructured":"Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840\u20136.","journal-title":"Nature"},{"key":"1135_CR4","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nature05487","volume":"444","author":"LF van Gaal","year":"2006","unstructured":"van Gaal LF, Mertens IL, de Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875\u201380.","journal-title":"Nature"},{"issue":"2","key":"1135_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S2213-8587(13)70062-7","volume":"1","author":"N Stefan","year":"2013","unstructured":"Stefan N, H\u00e4ring H-U, Hu FB, Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013;1(2):152\u201362.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1135_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1472-6823-14-9","volume":"14","author":"JV van Vliet-Ostaptchouk","year":"2014","unstructured":"van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, Doiron D, Fischer K, Foco L, Gaye A, Gogele M, Heier M, Hiekkalinna T, Joensuu A, Newby C, Pang C, Partinen E, Reischl E, Schwienbacher C, Tammesoo ML, Swertz MA, Burton P, Ferretti V, Fortier I, Giepmans L, Harris JR, Hillege HL, Holmen J, Jula A, Kootstra-Ros JE, Kvaloy K, Holmen TL, Mannisto S, Metspalu A, Midthjell K, Murtagh MJ, Peters A, Pramstaller PP, Saaristo T, Salomaa V, Stolk RP, Uusitupa M, van der Harst P, van der Klauw MM, Waldenberger M, Perola M, Wolffenbuttel BH. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord. 2014;14:9.","journal-title":"BMC Endocr Disord"},{"issue":"9","key":"1135_CR7","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.2337\/diacare.27.9.2222","volume":"27","author":"MP St-Onge","year":"2004","unstructured":"St-Onge MP, Janssen I, Heymsfield SB. Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual. Diabetes Care. 2004;27(9):2222\u20138.","journal-title":"Diabetes Care"},{"issue":"2","key":"1135_CR8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1161\/CIRCULATIONAHA.109.887521","volume":"121","author":"J Arnlov","year":"2010","unstructured":"Arnlov J, Ingelsson E, Sundstrom J, Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation. 2010;121(2):230\u20136.","journal-title":"Circulation"},{"key":"1135_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1089\/thy.2006.16.73","volume":"16","author":"MA Michalaki","year":"2006","unstructured":"Michalaki MA, Vagenakis AG, Leonardou AS, Argentou MN, Habeos IG, Makri MG, et al. Thyroid function in humans with morbid obesity. Thyroid. 2006;16:73\u20138.","journal-title":"Thyroid"},{"key":"1135_CR10","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1365-2265.2009.03640.x","volume":"72","author":"SM Boekholdt","year":"2010","unstructured":"Boekholdt SM, Titan SM, Wiersinga WM, Chatterjee K, Basart DC, Luben R, Wareham NJ, Khaw KT. Initial thyroid status and cardiovascular risk factors: the EPICNorfolk prospective population study. Clin Endocrinol (Oxf). 2010;72:404\u201310.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1135_CR11","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/j.1365-2265.2009.03698.x","volume":"72","author":"S Ruhla","year":"2010","unstructured":"Ruhla S, Weickert MO, Arafat AM, Osterhoff M, Isken F, Spranger J, Schofl C, Pfeiffer AF, Mohlig M. high normal TSH is associated with the metabolic syndrome. Clin Endocrinol (Oxf). 2010A;72:696\u2013701.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1135_CR12","doi-asserted-by":"publisher","first-page":"104318","DOI":"10.1155\/2014\/104318","volume":"2014","author":"JA Shin","year":"2014","unstructured":"Shin JA, Mo EY, Kim ES, Moon SD, Han JH. Association between lower normal free thyroxine concentrations and obesity phenotype in healthy euthyroid subjects. Int J Endocrinol. 2014;2014:104318.","journal-title":"Int J Endocrinol"},{"key":"1135_CR13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1089\/thy.2017.0454","volume":"28","author":"A Amouzegar","year":"2018","unstructured":"Amouzegar A, Kazemian E, Abdi H, Mansournia MA, Bakhtiyari M, Hosseini MS, et al. Association between thyroid function and development of different obesity phenotypes in euthyroid adults: a nine-year follow-up. Thyroid. 2018;28:458\u201364.","journal-title":"Thyroid"},{"key":"1135_CR14","doi-asserted-by":"publisher","first-page":"867","DOI":"10.4093\/dmj.2018.0130","volume":"43","author":"JM Kim","year":"2019","unstructured":"Kim JM, Kim BH, Lee H, Kim EH, Kim M, Kim JH, et al. The relationship between thyroid function and different obesity phenotypes in Korean euthyroid adults. Diabetes Metab J. 2019;43:867\u201378.","journal-title":"Diabetes Metab J"},{"key":"1135_CR15","first-page":"418","volume":"16","author":"F Azizi","year":"2013","unstructured":"Azizi F, Amouzegar A, Delshad H, Tohidi M, Mehran L, Mehrabi Y. Natural course of thyroid disease profile in a population in nutrition transition: Tehran Thyroid Study. Arch Iran Med. 2013;16:418\u201323.","journal-title":"Arch Iran Med"},{"key":"1135_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1745-6215-10-5","volume":"10","author":"F Azizi","year":"2009","unstructured":"Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, Mehrabi Y, Zahedi-Asl S. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009;10:5.","journal-title":"Trials"},{"key":"1135_CR17","first-page":"950","volume":"36","author":"A Amouzegar","year":"2013","unstructured":"Amouzegar A, Delshad H, Mehran L, Tohidi M, Khafaji F, Azizi F. Reference limit of thyrotropin (TSH) and free thyroxine (fT4) in thyroperoxidase positive and negative subjects: a population based study. J Endocrinol Invest. 2013;36:950\u20134.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"1135_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2337\/dc14-2391","volume":"38","author":"WC Hsu","year":"2015","unstructured":"Hsu WC, Araneta MR, Kanaya AM, Chiang JL, Fujimoto W. BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care. 2015;38(1):150\u20138.","journal-title":"Diabetes Care"},{"key":"1135_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fendo.2020.00068","volume":"11","author":"X Nie","year":"2020","unstructured":"Nie X, Ma X, Xu Y, Shen Y, Wang Y, Bao Y. Characteristics of serum thyroid hormones in different metabolic phenotypes of obesity. Front Endocrinol. 2020;11:68.","journal-title":"Front Endocrinol"},{"issue":"6","key":"1135_CR20","doi-asserted-by":"publisher","first-page":"867","DOI":"10.4093\/dmj.2018.0130","volume":"43","author":"JM Kim","year":"2019","unstructured":"Kim JM, Kim BH, Lee H, Kim EH, Kim M, Kim JH, Jeon YK, Kim SS, Kim IJ, Kim YK. The relationship between thyroid function and different obesity phenotypes in Korean Euthyroid Adults. Diabetes Metab J. 2019;43(6):867\u201378.","journal-title":"Diabetes Metab J"},{"issue":"7","key":"1135_CR21","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1089\/thy.2016.0557","volume":"27","author":"L Mehran","year":"2017","unstructured":"Mehran L, Amouzegar A, Bakhtiyari M, Mansournia MA, Rahimabad PK, Tohidi M, Azizi F. Variations in serum free thyroxine concentration within the reference range predicts the incidence of metabolic syndrome in non-obese adults: a cohort study. Thyroid. 2017;27(7):886\u201393.","journal-title":"Thyroid"},{"issue":"3","key":"1135_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.7326\/0003-4819-139-3-200308050-00010","volume":"139","author":"JE Silva","year":"2003","unstructured":"Silva JE. The thermogenic effect of thyroid hormone and its clinical implications. Ann Intern Med. 2003;139(3):205\u201313.","journal-title":"Ann Intern Med"},{"issue":"5","key":"1135_CR23","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/j.1365-2265.2009.03698.x","volume":"72","author":"S Ruhla","year":"2010","unstructured":"Ruhla S, Weickert MO, Arafat AM, et al. A high normal TSH is associated with the metabolic syndrome. Clin Endocrinol. 2010;72(5):696\u2013701.","journal-title":"Clin Endocrinol"},{"issue":"3","key":"1135_CR24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.maturitas.2009.01.007","volume":"62","author":"HT Park","year":"2009","unstructured":"Park HT, Cho GJ, Ahn KH, et al. Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women. Maturitas. 2009;62(3):301\u20135.","journal-title":"Maturitas"},{"issue":"2","key":"1135_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1210\/jc.2006-1718","volume":"92","author":"A Roos","year":"2007","unstructured":"Roos A, Bakker SJL, Links TP, Gans ROB, Wolffenbuttel BHR. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab. 2007;92(2):491\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1135_CR26","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1210\/jc.2004-2225","volume":"90","author":"N Knudsen","year":"2005","unstructured":"Knudsen N, Laurberg P, Rasmussen LB, et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab. 2005;90(7):4019\u201324.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1135_CR27","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/ijo.2009.140","volume":"33","author":"M Nannipieri","year":"2009","unstructured":"Nannipieri M, Cecchetti F, Anselmino M, et al. Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and\/or type 2 diabetes: effects of weight loss. Int J Obes. 2009;33(9):1001\u20136.","journal-title":"Int J Obes"},{"issue":"2","key":"1135_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.mce.2009.06.005","volume":"316","author":"T Reinehr","year":"2010","unstructured":"Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol. 2010;316(2):165\u201371.","journal-title":"Mol Cell Endocrinol"},{"key":"1135_CR29","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1161\/01.HYP.0000147893.08533.d8","volume":"44","author":"RJ Huggett","year":"2004","unstructured":"Huggett RJ, Burns J, Mackintosh AF, Mary DA. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension. 2004;44:847\u201352.","journal-title":"Hypertension"},{"key":"1135_CR30","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1097\/00004872-200412000-00019","volume":"22","author":"G Grassi","year":"2004","unstructured":"Grassi G, Dell\u2019Oro R, Facchini A, Quarti Trevano F, Bolla GB, Mancia G. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens. 2004;22:2363\u20139.","journal-title":"J Hypertens"},{"key":"1135_CR31","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1038\/oby.2008.382","volume":"16","author":"G De Pergola","year":"2008","unstructured":"De Pergola G, Giorgino F, Benigno R, Guida P, Giorgino R. Independent influence of insulin, catecholamines, and thyroid hormones on metabolic syndrome. Obesity (Silver Spring). 2008;16:2405\u201311.","journal-title":"Obesity (Silver Spring)"},{"key":"1135_CR32","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1210\/jc.2006-1718","volume":"92","author":"A Roos","year":"2007","unstructured":"Roos A, Bakker SJ, Links TP, Gans RO, Wolffenbuttel BH. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab. 2007;92:491\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"1135_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1507\/endocrj.K10E-272","volume":"58","author":"Y Lai","year":"2011","unstructured":"Lai Y, Wang J, Jiang F, Wang B, Chen Y, Li M, Liu H, Li C, Xue H, Li N, Yu J, Shi L, Bai X, Hou X, Zhu L, Lu L, Wang S, Xing Q, Teng X, Teng W, Shan Z. The relationship between serum thyrotropin and components of metabolic syndrome. Endocr J. 2011;58:23\u201330.","journal-title":"Endocr J"},{"key":"1135_CR34","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1089\/thy.2014.0103","volume":"24","author":"L Mehran","year":"2014","unstructured":"Mehran L, Amouzegar A, Tohidi M, Moayedi M, Azizi F. Serum free thyroxine concentration is associated with metabolic syndrome in euthyroid subjects. Thyroid. 2014;24:1566\u201374.","journal-title":"Thyroid"},{"key":"1135_CR35","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1172\/JCI60047","volume":"122","author":"GA Brent","year":"2012","unstructured":"Brent GA. Mechanisms of thyroid hormone action. J Clin Invest. 2012;122:3035\u201343.","journal-title":"J Clin Invest"},{"key":"1135_CR36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1210\/jcem-51-1-106","volume":"51","author":"KD Burman","year":"1980","unstructured":"Burman KD, Latham KR, Djuh YY, Smallridge RC, Tseng YC, Lukes YG, Maunder R, Wartofsky L. Solubilized nuclear thyroid hormone receptors in circulating human mononuclear cells. J Clin Endocrinol Metab. 1980;51:106\u201316.","journal-title":"J Clin Endocrinol Metab"},{"key":"1135_CR37","first-page":"51","volume":"70","author":"T Reinehr","year":"2008","unstructured":"Reinehr T, Isa A, de Sousa G, Dieffenbach R, Andler W. Thyroid hormones and their relation to weight status. Horm Res. 2008;70:51\u20137.","journal-title":"Horm Res"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01135-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01135-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01135-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T03:34:17Z","timestamp":1685417657000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01135-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1135"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01135-1","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]},"assertion":[{"value":"3 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"According to the 2013 Helsinki Declaration guidelines, the protocol of this study was approved by the ethics committee of Research Institute for Endocrine Sciences (RIES) of Shahid Beheshti University of Medical Sciences (Code: IR.SBMU.ENDOCRINE.REC.1400.117). In addition, each participant signed a consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have given consent for the paper to be published by the corresponding author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"179"}}